ATAI Life Sciences NV (ATAI)
1.17
-0.02
(-1.68%)
USD |
NASDAQ |
Sep 27, 16:00
1.175
0.00 (0.00%)
After-Hours: 20:00
ATAI Life Sciences Free Cash Flow: -79.22M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -79.22M |
| March 31, 2024 | -85.73M |
| December 31, 2023 | -84.71M |
| September 30, 2023 | -93.46M |
| June 30, 2023 | -103.60M |
| March 31, 2023 | -103.00M |
| December 31, 2022 | -105.49M |
| September 30, 2022 | -95.63M |
| Date | Value |
|---|---|
| June 30, 2022 | -95.48M |
| March 31, 2022 | -71.72M |
| December 31, 2021 | -64.37M |
| September 30, 2021 | -49.77M |
| June 30, 2021 | -26.79M |
| March 31, 2021 | -33.63M |
| December 31, 2020 | -20.82M |
Free Cash Flow Range, Past 5 Years
-105.49M
Minimum
Dec 2022
-20.82M
Maximum
Dec 2020
-74.23M
Average
-84.71M
Median
Dec 2023
Free Cash Flow Benchmarks
| Affimed NV | -94.25M |
| InflaRx NV | -46.46M |
| BioNTech SE | 2.515B |
| Immatics NV | -47.93M |
| CureVac NV | -354.88M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.23M |
| Cash from Investing (Quarterly) | 16.30M |
| Cash from Financing (Quarterly) | 0.326M |
| Free Cash Flow Per Share (Quarterly) | -0.1012 |
| Free Cash Flow to Equity (Quarterly) | -15.13M |
| Free Cash Flow to Firm (Quarterly) | -15.64M |
| Free Cash Flow Yield | -40.74% |